The first dual-purpose, external trigeminal nerve stimulation device to treat and prevent acute migraine is now available over-the-counter to adults over age 18. The US Food and Drug Administration ...

Cefaly smaller anti-migraine device Previously, the external trigeminal nerve stimulator was only available with a prescription. The Food and Drug Administration (FDA) has cleared Cefaly Dual (Cefaly ...

The Buy Back allows CEFALY users to trade up their device for a smaller, sleeker, device with two migraine treatment programs, rechargeable battery, and a renewed 60-day money back guarantee NEW YORK, ...

Renowned for helping prevent migraine attacks, a new FDA clearance paves way for more Cefaly devices that can now stop a migraine in progress and prevent a future episode too The Cefaly® ACUTE can ...

Cefaly Technology sprl reported results from a phase III clinical trial showing that two-hour treatment with its Cefaly Dual external trigeminal nerve stimulation (e-TNS) device is a safe and ...

NEW YORK, May 25, 2021 /PRNewswire/ — CEFALY Technology today announced the release of the new CEFALY DUAL Enhanced, the next-generation model of the dual-purpose, external Trigeminal Nerve Stimulator ...

First Real-World, Randomized, Sham-Controlled Clinical Trial of 2-Hour External Trigeminal Nerve Stimulation (e-TNS) in Finds That the e-TNS CEFALY Device Is Effective in Treating Acute Migraine Pain ...

Please provide your email address to receive an email when new articles are posted on . Cefaly Technology’s nerve stimulation device, when compared with sham stimulation, was more effective in ...

DARIEN, Conn., Dec. 20, 2022 /PRNewswire/ -- Medical device maker CEFALY Technology has announced that owners of older CEFALY devices can trade them in for credit toward the purchase of the all-new ...

NEW YORK, May 25, 2021 /PRNewswire/ — CEFALY Technology today announced the release of the new CEFALY DUAL Enhanced, the next-generation model of the dual-purpose, external Trigeminal Nerve Stimulator ...